Brad Blum

Accomplished executive with 20+ years of experience scaling ventures across biotech, nanotechnology, and pharmaceutical sectors. Proven track record in launching high-growth businesses, commercializing IP, leading global regulatory strategies, and executing successful exits. Adept at bridging innovation with execution, forming strategic partnerships, and leading cross-functional teams to deliver measurable impact.

Title: COO, Business Development

I’m excited to bring decades of executive leadership commercial development to the team. I look forward to driving innovation, scaling breakthrough technologies, and building long-term partnerships that deliver meaningful impact. My door is always open, and I welcome the opportunity to collaborate with each of you.

• COO, DecaCarbon, 12/01/24, Present, Leading the commercial strategy and scale-up of a carbon innovation company focused on Activated Carbon, energy storage, environmental remediation, and sustainable materials, Driving strategic partnerships and off-take agreements in aerospace, pharma, and clean energy sectors, Supporting CEO with multi-million-dollar capital raise and IP development initiatives.
• Co-Founder, Pelame LLC / Nanoceutical Solutions, 01/01/16, 12/31/25, Developed and commercialized nano-sized vitamins with clinically validated bioavailability, Scaled direct-to consumer nano-supplement company from startup to $700K/ month in online sales., Pioneered advanced nano techniques that improved bioavailability of key nutraceutical compounds, resulting in the successful market launch of 18 premium products., Oversaw nano-processing of poorly soluble APIs, optimized for dissolution and shelf stability., Directed cross-functional teams spanning R&D, regulatory, supply chain, and digital marketing.
• COO, MD2RX, 01/01/19, 12/31/22, Managed operations of a high-volume online Class G pharmacy, processing 720+ daily prescriptions with 99.3% accuracy., Reduced staff turnover by 32% through implementation of performance and training systems., Maintained full compliance with DEA, HIPAA, and Texas State Board of Pharmacy regulations., Streamlined inventory and vendor management, reducing procurement costs while ensuring uninterrupted fulfillment., Sold business to PillPak (Amazon subsidiary) in 2022.
• Founder & CEO, RegenerMed, LLC, 01/01/03, 12/31/16, Successfully registered one of the first biological drugs in Mexico (COFEPRIS), Expanded biologic drug registrations across Ukraine, Russia, Hong Kong, Columbia, Panama, and Venezuela, Sold company to Innovare R&D in 2016, Managed international regulatory strategies and compliance, Oversaw global sales and marketing execution